Close

Production & Manufacturing

Imprint Codes for Oral Medications

What are Imprint Codes? All approved prescription and over-the-counter solid, oral dosage form medications in the U.S. are required by the Food and Drug Administration (FDA) to have a unique imprint. This also applies to biological drug products and homeopathic...

Antibiotics and Birth Control Pill Interactions: Fact or Fallacy?

Are you concerned when you receive an antibiotic prescription but you also take oral contraceptives? For many years, women were counseled that their birth control pill might become less effective if they also took a course of antibiotic. The...

Beximco Pharma forms JV with Malaysia-based BioCare Manufacturing

Beximco Pharmaceuticals Limited the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces the creation of a joint venture with BioCare Manufacturing Sdn Bhd based in Malaysia, as the Company’s first overseas manufacturing collaboration. ...

Baxter in Manesar,Waluj and Alathur

Baxter in Manesar: Baxter’s facility in Manesar, Gurgaon demonstrates excellence in manufacturing for the company’s Medication Delivery and Renal businesses, producing IV and PD solutions. The 21,000 sq.m. facility in Manesar was constructed by Baxter in...

Boehringer Ingelheim BioXcellenceâ„¢ offers reliable world-class biopharmaceuticals contract manufacturing to the pharmaceutical and biotechnology industry.

We offer a complete range of services, from cell line and strain development through process development and large-scale manufacturing to fill and finish. Our extensive portfolio of capabilities and technologies includes the production of antibodies, recombinant proteins, non-antibody scaffolds,...

The road to digital success in pharma

Pharmaceutical companies are running hard to keep pace with changes brought about by digital technology. Mobile communications, the cloud, advanced analytics, and the Internet of Things are among the innovations that are starting to transform the healthcare industry in...

Galena Biopharma Acquires Mills Pharmaceuticals

Galena Biopharma, a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced it has acquired Mills Pharmaceuticals, which has the worldwide rights to GALE-401 (Anagrelide CR), a patented,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read